Relevance of ultraviolet-induced N-ras oncogene point mutations in development of primary human cutaneous melanoma (original) (raw)

. 1996 Sep;149(3):883–893.

Abstract

Intermittent or recreational exposure to sunlight is thought to contribute to development of human cutaneous melanoma. We investigated the incidence of ras oncogene mutation in human cutaneous melanoma in connection to sun-exposed body sites in the patient, using a large series of DNA samples derived from paraffin-embedded material as well as from fresh tumor samples and cell lines. We first show that, of the ras family, predominantly N-ras is activated (15%), whereas rarely H-ras or K-ras are mutated. The occurrence of N-ras mutations correlates with continuous exposure to sunlight of the primary tumor site. Of all tumors initiated on chronically sun-exposed body sites, 26% contained mutated N-ras, in contrast to 0% of sun-protected melanomas. Melanoma lesions obtained from patients from North or Central Europe contained fewer N-ras mutations (12%) as compared with patients from Australia (24%). Mutations were specifically associated with nodular melanoma and to a lesser extent with lentigo malignant melanoma. N-ras mutations did not correlate with metastasis or survival parameters. This study identifies a subset of cutaneous melanomas that contain in the primary lesion ultraviolet-induced N-ras mutations, which are maintained through further progression.

883

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albino A. P., Le Strange R., Oliff A. I., Furth M. E., Old L. J. Transforming ras genes from human melanoma: a manifestation of tumour heterogeneity? Nature. 1984 Mar 1;308(5954):69–72. doi: 10.1038/308069a0. [DOI] [PubMed] [Google Scholar]
  2. Albino A. P., Nanus D. M., Mentle I. R., Cordon-Cardo C., McNutt N. S., Bressler J., Andreeff M. Analysis of ras oncogenes in malignant melanoma and precursor lesions: correlation of point mutations with differentiation phenotype. Oncogene. 1989 Nov;4(11):1363–1374. [PubMed] [Google Scholar]
  3. Ananthaswamy H. N., Price J. E., Goldberg L. H., Bales E. S. Detection and identification of activated oncogenes in human skin cancers occurring on sun-exposed body sites. Cancer Res. 1988 Jun 15;48(12):3341–3346. [PubMed] [Google Scholar]
  4. Armstrong B. K., Kricker A. Cutaneous melanoma. Cancer Surv. 1994;19-20:219–240. [PubMed] [Google Scholar]
  5. Ball N. J., Yohn J. J., Morelli J. G., Norris D. A., Golitz L. E., Hoeffler J. P. Ras mutations in human melanoma: a marker of malignant progression. J Invest Dermatol. 1994 Mar;102(3):285–290. doi: 10.1111/1523-1747.ep12371783. [DOI] [PubMed] [Google Scholar]
  6. Boom R., Sol C. J., Salimans M. M., Jansen C. L., Wertheim-van Dillen P. M., van der Noordaa J. Rapid and simple method for purification of nucleic acids. J Clin Microbiol. 1990 Mar;28(3):495–503. doi: 10.1128/jcm.28.3.495-503.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bos J. L. ras oncogenes in human cancer: a review. Cancer Res. 1989 Sep 1;49(17):4682–4689. [PubMed] [Google Scholar]
  8. Brash D. E., Rudolph J. A., Simon J. A., Lin A., McKenna G. J., Baden H. P., Halperin A. J., Pontén J. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):10124–10128. doi: 10.1073/pnas.88.22.10124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Daya-Grosjean L., Robert C., Drougard C., Suarez H., Sarasin A. High mutation frequency in ras genes of skin tumors isolated from DNA repair deficient xeroderma pigmentosum patients. Cancer Res. 1993 Apr 1;53(7):1625–1629. [PubMed] [Google Scholar]
  10. Der C. J., Finkel T., Cooper G. M. Biological and biochemical properties of human rasH genes mutated at codon 61. Cell. 1986 Jan 17;44(1):167–176. doi: 10.1016/0092-8674(86)90495-2. [DOI] [PubMed] [Google Scholar]
  11. Dumaz N., Drougard C., Sarasin A., Daya-Grosjean L. Specific UV-induced mutation spectrum in the p53 gene of skin tumors from DNA-repair-deficient xeroderma pigmentosum patients. Proc Natl Acad Sci U S A. 1993 Nov 15;90(22):10529–10533. doi: 10.1073/pnas.90.22.10529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Elwood J. M., Gallagher R. P., Hill G. B., Pearson J. C. Cutaneous melanoma in relation to intermittent and constant sun exposure--the Western Canada Melanoma Study. Int J Cancer. 1985 Apr 15;35(4):427–433. doi: 10.1002/ijc.2910350403. [DOI] [PubMed] [Google Scholar]
  13. Elwood J. M., Koh H. K. Etiology, epidemiology, risk factors, and public health issues of melanoma. Curr Opin Oncol. 1994 Mar;6(2):179–187. doi: 10.1097/00001622-199403000-00011. [DOI] [PubMed] [Google Scholar]
  14. Fearon E. R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990 Jun 1;61(5):759–767. doi: 10.1016/0092-8674(90)90186-i. [DOI] [PubMed] [Google Scholar]
  15. Feig L. A., Cooper G. M. Relationship among guanine nucleotide exchange, GTP hydrolysis, and transforming potential of mutated ras proteins. Mol Cell Biol. 1988 Jun;8(6):2472–2478. doi: 10.1128/mcb.8.6.2472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Gallagher R. P., Hill G. B., Bajdik C. D., Coldman A. J., Fincham S., McLean D. I., Threlfall W. J. Sunlight exposure, pigmentation factors, and risk of nonmelanocytic skin cancer. II. Squamous cell carcinoma. Arch Dermatol. 1995 Feb;131(2):164–169. [PubMed] [Google Scholar]
  17. Garbe C., Büttner P., Weiss J., Soyer H. P., Stocker U., Krüger S., Roser M., Weckbecker J., Panizzon R., Bahmer F. Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society. J Invest Dermatol. 1994 May;102(5):695–699. doi: 10.1111/1523-1747.ep12374280. [DOI] [PubMed] [Google Scholar]
  18. Holman C. D., Armstrong B. K. Cutaneous malignant melanoma and indicators of total accumulated exposure to the sun: an analysis separating histogenetic types. J Natl Cancer Inst. 1984 Jul;73(1):75–82. [PubMed] [Google Scholar]
  19. Holman C. D., Armstrong B. K., Heenan P. J. Relationship of cutaneous malignant melanoma to individual sunlight-exposure habits. J Natl Cancer Inst. 1986 Mar;76(3):403–414. [PubMed] [Google Scholar]
  20. Keijzer W., Mulder M. P., Langeveld J. C., Smit E. M., Bos J. L., Bootsma D., Hoeijmakers J. H. Establishment and characterization of a melanoma cell line from a xeroderma pigmentosum patient: activation of N-ras at a potential pyrimidine dimer site. Cancer Res. 1989 Mar 1;49(5):1229–1235. [PubMed] [Google Scholar]
  21. Lübbe J., Reichel M., Burg G., Kleihues P. Absence of p53 gene mutations in cutaneous melanoma. J Invest Dermatol. 1994 May;102(5):819–821. doi: 10.1111/1523-1747.ep12381544. [DOI] [PubMed] [Google Scholar]
  22. Lübbert M., Mirro J., Jr, Miller C. W., Kahan J., Isaac G., Kitchingman G., Mertelsmann R., Herrmann F., McCormick F., Koeffler H. P. N-ras gene point mutations in childhood acute lymphocytic leukemia correlate with a poor prognosis. Blood. 1990 Mar 1;75(5):1163–1169. [PubMed] [Google Scholar]
  23. MacKie R. M., Aitchison T. Severe sunburn and subsequent risk of primary cutaneous malignant melanoma in scotland. Br J Cancer. 1982 Dec;46(6):955–960. doi: 10.1038/bjc.1982.307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. MacKie R. M., McHenry P., Hole D. Accelerated detection with prospective surveillance for cutaneous malignant melanoma in high-risk groups. Lancet. 1993 Jun 26;341(8861):1618–1620. doi: 10.1016/0140-6736(93)90758-9. [DOI] [PubMed] [Google Scholar]
  25. Mackie R. M. The role of sunlight in the aetiology of cutaneous malignant melanoma. Clin Exp Dermatol. 1981 Jul;6(4):407–410. doi: 10.1111/j.1365-2230.1981.tb02326.x. [DOI] [PubMed] [Google Scholar]
  26. Martin G. A., Viskochil D., Bollag G., McCabe P. C., Crosier W. J., Haubruck H., Conroy L., Clark R., O'Connell P., Cawthon R. M. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell. 1990 Nov 16;63(4):843–849. doi: 10.1016/0092-8674(90)90150-d. [DOI] [PubMed] [Google Scholar]
  27. Murakami Y., Hayashi K., Hirohashi S., Sekiya T. Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res. 1991 Oct 15;51(20):5520–5525. [PubMed] [Google Scholar]
  28. Nelemans P. J., Kiemeney L. A., Rampen F. H., Straatman H., Verbeek A. L. Trends in mortality from malignant cutaneous melanoma in The Netherlands, 1950-1988. Eur J Cancer. 1992;29A(1):107–111. doi: 10.1016/0959-8049(93)90585-4. [DOI] [PubMed] [Google Scholar]
  29. Nishigori C., Wang S., Miyakoshi J., Sato M., Tsukada T., Yagi T., Imamura S., Takebe H. Mutations in ras genes in cells cultured from mouse skin tumors induced by ultraviolet irradiation. Proc Natl Acad Sci U S A. 1994 Jul 19;91(15):7189–7193. doi: 10.1073/pnas.91.15.7189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Orita M., Iwahana H., Kanazawa H., Hayashi K., Sekiya T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2766–2770. doi: 10.1073/pnas.86.8.2766. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Padua R. A., Barrass N. C., Currie G. A. Activation of N-ras in a human melanoma cell line. Mol Cell Biol. 1985 Mar;5(3):582–585. doi: 10.1128/mcb.5.3.582. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Pelletier J., Bruening W., Kashtan C. E., Mauer S. M., Manivel J. C., Striegel J. E., Houghton D. C., Junien C., Habib R., Fouser L. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell. 1991 Oct 18;67(2):437–447. doi: 10.1016/0092-8674(91)90194-4. [DOI] [PubMed] [Google Scholar]
  33. Pierceall W. E., Ananthaswamy H. N. Transformation of NIH3T3 cells by transfection with UV-irradiated human c-Ha-ras-1 proto-oncogene DNA. Oncogene. 1991 Nov;6(11):2085–2091. [PubMed] [Google Scholar]
  34. Raybaud F., Noguchi T., Marics I., Adelaide J., Planche J., Batoz M., Aubert C., de Lapeyriere O., Birnbaum D. Detection of a low frequency of activated ras genes in human melanomas using a tumorigenicity assay. Cancer Res. 1988 Feb 15;48(4):950–953. [PubMed] [Google Scholar]
  35. Seeburg P. H., Colby W. W., Capon D. J., Goeddel D. V., Levinson A. D. Biological properties of human c-Ha-ras1 genes mutated at codon 12. Nature. 1984 Nov 1;312(5989):71–75. doi: 10.1038/312071a0. [DOI] [PubMed] [Google Scholar]
  36. Sekiya T., Fushimi M., Hori H., Hirohashi S., Nishimura S., Sugimura T. Molecular cloning and the total nucleotide sequence of the human c-Ha-ras-1 gene activated in a melanoma from a Japanese patient. Proc Natl Acad Sci U S A. 1984 Aug;81(15):4771–4775. doi: 10.1073/pnas.81.15.4771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Shukla V. K., Hughes D. C., Hughes L. E., McCormick F., Padua R. A. ras mutations in human melanotic lesions: K-ras activation is a frequent and early event in melanoma development. Oncogene Res. 1989;5(2):121–127. [PubMed] [Google Scholar]
  38. Slebos R. J., Kibbelaar R. E., Dalesio O., Kooistra A., Stam J., Meijer C. J., Wagenaar S. S., Vanderschueren R. G., van Zandwijk N., Mooi W. J. K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. N Engl J Med. 1990 Aug 30;323(9):561–565. doi: 10.1056/NEJM199008303230902. [DOI] [PubMed] [Google Scholar]
  39. Streetly A., Markowe H. Changing trends in the epidemiology of malignant melanoma: gender differences and their implications for public health. Int J Epidemiol. 1995 Oct;24(5):897–907. doi: 10.1093/ije/24.5.897. [DOI] [PubMed] [Google Scholar]
  40. Trahey M., McCormick F. A cytoplasmic protein stimulates normal N-ras p21 GTPase, but does not affect oncogenic mutants. Science. 1987 Oct 23;238(4826):542–545. doi: 10.1126/science.2821624. [DOI] [PubMed] [Google Scholar]
  41. Trimble W. S., Johnson P. W., Hozumi N., Roder J. C. Inducible cellular transformation by a metallothionein-ras hybrid oncogene leads to natural killer cell susceptibility. Nature. 1986 Jun 19;321(6072):782–784. doi: 10.1038/321782a0. [DOI] [PubMed] [Google Scholar]
  42. Van Elsas A., Nijman H. W., Van der Minne C. E., Mourer J. S., Kast W. M., Melief C. J., Schrier P. I. Induction and characterization of cytotoxic T-lymphocytes recognizing a mutated p21ras peptide presented by HLA-A*0201. Int J Cancer. 1995 May 4;61(3):389–396. doi: 10.1002/ijc.2910610319. [DOI] [PubMed] [Google Scholar]
  43. Van der Lubbe J. L., Rosdorff H. J., Bos J. L., Van der Eb A. J. Activation of N-ras induced by ultraviolet irradiation in vitro. Oncogene Res. 1988;3(1):9–20. [PubMed] [Google Scholar]
  44. Ziegler A., Jonason A. S., Leffell D. J., Simon J. A., Sharma H. W., Kimmelman J., Remington L., Jacks T., Brash D. E. Sunburn and p53 in the onset of skin cancer. Nature. 1994 Dec 22;372(6508):773–776. doi: 10.1038/372773a0. [DOI] [PubMed] [Google Scholar]
  45. Ziegler A., Leffell D. J., Kunala S., Sharma H. W., Gailani M., Simon J. A., Halperin A. J., Baden H. P., Shapiro P. E., Bale A. E. Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc Natl Acad Sci U S A. 1993 May 1;90(9):4216–4220. doi: 10.1073/pnas.90.9.4216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. van 't Veer L. J., Burgering B. M., Versteeg R., Boot A. J., Ruiter D. J., Osanto S., Schrier P. I., Bos J. L. N-ras mutations in human cutaneous melanoma from sun-exposed body sites. Mol Cell Biol. 1989 Jul;9(7):3114–3116. doi: 10.1128/mcb.9.7.3114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. van der Schroeff J. G., Evers L. M., Boot A. J., Bos J. L. Ras oncogene mutations in basal cell carcinomas and squamous cell carcinomas of human skin. J Invest Dermatol. 1990 Apr;94(4):423–425. doi: 10.1111/1523-1747.ep12874504. [DOI] [PubMed] [Google Scholar]